Shanghai RAAS Blood Products Co., Ltd. is principally engaged in research, development, manufacture and distribution of blood products. The Company provides human albumin, human immunoglobulin for intravenous injection, human coagulation factor, human prothrombin complex, human fibrinogen, human thrombin and human fibrin sealant, among others. The Company distributes its products in domestic and overseas markets. As of December 31, 2010, the Company had 12 subsidiaries, which involved in collection of human blood.

Shanghai Raas Blood Products Co. Ltd manufactures commercial blood products principally in China. The company’s plasma products include high and intermediate purity coagulation factor VIII; high purity coagulation factor IX; prothrombin complex concentrate; intravenous immunoglobulin G; intramuscular immunoglobulin G; hyperimmune globulin preparations against hepatitis B and tetanus; thrombin for topical application; fibrin sealant; and human albumin. Its biological products comprise AlbuRAAS, which is in clinical studies for human albumin in hepatitic disease and surgery; GammaRAAS that prevents infection and treats various immune disorders; HemoRAAS for treating hemophilia; ProthoRAAS for the treatment of acquired coagulation disorders; FibroRAAS for coagulation disorders, principally in gynecology; FibrinSealRAAS for a range topical sealant for surgery; and ThrombiRAAS, an oral application for internal bleeding. The company is based in Shanghai, China.